14-07-2026 21:02 via drugs.com

Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease

TUESDAY, July 14, 2026-- Consensus statements have been developed for screening, diagnosis, and treatment of rheumatoid arthritis-associated interstitial lung disease (ILD); the statements were published online June 5 in The Lancet Respiratory...
Read more »